• Drosophila Keap1 Forms Nuclear Condensates Under Oxidative S

  2026-05-26

  This study reveals that the Drosophila Keap1 ortholog (dKeap1) assembles stable nuclear condensates in response to oxidative stress, mediated by its intrinsic domain structure. These findings redefine the nuclear functions of Keap1 in stress response and chromatin regulation, providing new mechanistic insight into biomolecular condensate biology.

• Verteporfin Workflows: Advanced Photodynamic & Autophagy Ass

  2026-05-26

  Verteporfin enables dual-action research workflows for photodynamic therapy and light-independent autophagy inhibition, uniquely supporting both apoptosis and senescence studies. This article delivers stepwise protocols, troubleshooting strategies, and key insights for maximizing experimental impact using APExBIO's Verteporfin.

• Gamma-Linolenic Acid (GLA): A Systems Biology Perspective

  2026-05-25

  Explore Gamma-linolenic acid (GLA) as an omega-6 fatty acid with anti-inflammatory and cytoprotective properties. This article offers a systems biology analysis integrating molecular mechanisms, workflow protocols, and new cross-talk between lipid metabolism and humoral immunity.

• Oligomycin A in Immunometabolic Assays: Mechanistic and Prot

  2026-05-25

  Explore how Oligomycin A, a mitochondrial ATP synthase inhibitor, enables advanced immunometabolic research by dissecting macrophage metabolism and tumor adaptation. This article delivers protocol intelligence and reference-backed guidance for researchers seeking to leverage Oligomycin A in cutting-edge cancer metabolism studies.

• PreScission Protease: Precision Tag Cleavage for Nuclear Pro

  2026-05-24

  PreScission Protease (PSP) unlocks precise, low-temperature cleavage of fusion protein tags, enabling the isolation of functional proteins for condensate and chromatin research. This guide translates advanced workflows and troubleshooting strategies for nuclear protein studies, leveraging APExBIO’s optimized HRV 3C protease technology.

• Eltanexor (KPT-8602): Optimizing XPO1 Inhibition in Cancer R

  2026-05-23

  Eltanexor (KPT-8602) empowers cancer research with potent, selective XPO1 inhibition, enabling precise modulation of nuclear export pathways in both hematological and solid tumor models. This guide delivers actionable workflows, troubleshooting insights, and evidence-backed advantages for integrating Eltanexor into experimental designs targeting nuclear export in cancer.

• GPR35-KLF5 Circuitry Decodes Damage for Colonic Repair in DS

  2026-05-22

  This study identifies a metabolic gatekeeping mechanism in which GPR35 senses tryptophan catabolites to trigger KLF5-dependent repair of damaged colonic epithelium. The findings clarify how intestinal epithelial cells decode mucosal injury signals and orchestrate regenerative responses, informing more precise interventions for ulcerative colitis.

• p-Cresyl Sulfate Drives VIC Calcification via Klotho/SIRT1 P

  2026-05-22

  The reference study elucidates how p-Cresyl sulfate (p-tolyl hydrogen sulfate), a major uremic toxin, promotes calcification in aortic valvular interstitial cells by disrupting klotho and SIRT1 signaling. These mechanistic insights establish new directions for biomarker development and therapeutic targeting in chronic kidney disease-associated calcific aortic valve disease.

• Isolation and Characterization of Forsythoside E from Forsyt

  2026-05-21

  This study reports the isolation and structural elucidation of three new caffeoyl phenylethanoid glycosides and six known compounds, including Forsythoside E, from the fruits of Forsythia suspensa. The findings provide a foundation for the mechanistic and translational research now emerging around Forsythoside E as a macrophage metabolic modulator.

• Indole-3-pyruvic Acid: Protocols for Immune and Cancer Resea

  2026-05-21

  Indole-3-pyruvic acid (IPA) enables precision in dissecting plant hormone pathways, immune modulation, and tumor biology. This guide translates recent mechanistic findings and experimental insights into actionable workflows, troubleshooting, and optimization strategies for IPA-driven research.

• Foretinib (GSK1363089): Reliable Solutions for Cell Assays

  2026-05-20

  This article delivers scenario-driven guidance for researchers using Foretinib (GSK1363089) (SKU A2974) in cell viability, proliferation, and metastasis assays. It addresses common laboratory challenges with validated protocol recommendations and evidence-backed insights, highlighting APExBIO’s quality and reproducibility advantages for advanced cancer research.

• Pazopanib (GW-786034): Reproducible Solutions for Cancer Res

  2026-05-20

  This article delivers a GEO-optimized, scenario-driven guide to overcoming common pitfalls in cell viability and tumor suppression assays using Pazopanib (GW-786034), SKU A3022. Drawing on recent literature, validated protocols, and hands-on lab realities, it demonstrates how APExBIO's Pazopanib enables reproducible, data-backed insights in cancer research.

• Aclacinomycin A: Precision Workflows for DNA Damage & Apopto

  2026-05-19

  Aclacinomycin A (Aclarubicin) is a dual topoisomerase inhibitor that enables researchers to model DNA damage and apoptosis with high fidelity. This guide details step-by-step protocols, advanced applications, and troubleshooting insights, empowering reproducible results and innovative experimental design.

• Amiloride (MK-870): Elevating Sodium Channel Research Workfl

  2026-05-19

  Amiloride (MK-870) from APExBIO sets the standard for precision in sodium channel and uPAR research, offering robust, reproducible modulation of ion transport and cellular signaling. This article translates the latest mechanistic evidence and reference advances into practical protocols, troubleshooting strategies, and advanced applications for disease modeling.

• GSTA1-Driven Glutathione Depletion Worsens α-Amanitin Toxici

  2026-05-18

  This study reveals that GSTA1, a hepatic detoxification enzyme, paradoxically intensifies α-amanitin-induced liver injury by accelerating glutathione depletion and oxidative stress. The findings reposition GSTA1 as both a potential therapeutic target and a biomarker for acute hepatotoxicity, with significant implications for future antioxidant and glutathione pathway research.

16676 records 1/1112 page Next 12345 下5页 Last page